DAIICHI SANKYO COMPANY, LIMITED

Top Management Presentation Financial Results for FY2016 Q2

November 1, 2016

Font Size
  • S
  • M
  • L

Top Management Presentation Financial Results for FY2016 Q2

DAIICHI SANKYO COMPANY, LIMITED
Joji Nakayama
President and CEO
Glenn Gormley MD PhD
Senior Executive Officer Global Head of R&D

Play List

from the beginning

Top Management Presentation Financial Results for FY2016 Q2 (April 1 - September 30, 2016)
FY2016 Q2 Financial Results
FY2016 Revised Consolidated Forecast
Progress of 5-Year Business Plan
Strategic Target 1:Grow Edoxaban
Strategic Target 2:Establish Oncology Business
Strategic Target 3:Grow as No.1 company in Japan
Strategic Target 4:Expand US Businesses
Strategic Target 5:Continuously Generate Innovative Medicine Changing SOC
Shareholder Returns
R&D Update
Q&A
  • Forward-Looking Statements
  • System Requirements
  • Questionnaire